Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2025-12-24 @ 6:38 PM
NCT ID:
NCT00696657
Eligibility Criteria:
Inclusion Criteria:
* Men and women-not-of-childbearing potential diagnosed with type 2 diabetes for at least three months
* Stable treatment regimen with either metformin (at least 1500 mg) or diet and exercise alone for at least three months
* HbA1c: 7.0-10.0 % (both inclusive)
* Body weight between 60 kg and 110 kg
Exclusion Criteria:
* Treatment with insulin, GLP-1 receptor agonists (including liraglutide), dipeptidyl peptidase-4 inhibitors, sulphonylurea, thiazolidinediones, Alpha-GIs, or any investigational drug, within the last three months
* Impaired liver or kidney function
* Proliferative retinopathy or maculopathy requiring acute treatment
* Clinically significant active cardiovascular disease and uncontrolled treated/untreated hypertension
* Recurrent major hypoglycaemia or hypoglycaemic unawareness
* Present or planned use of any drug which could interfere with the glucose levels (e.g. systemic corticosteroids)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00696657
Study Brief:
Protocol Section:
NCT00696657